Integral Derivatives’s Express Scripts Holding Company ESRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
$449K Sell
6,500
-4,300
-40% -$328K 0.01% 411
2017
Q4
$806K Sell
10,800
-27,800
-72% -$1.78M 0.02% 557
2017
Q3
$2.44M Buy
38,600
+24,900
+182% +$1.55M 0.04% 264
2017
Q2
$875K Buy
+13,700
New +$860K 0.02% 522
2016
Q2
Sell
-10,000
Closed -$687K 1152
2016
Q1
$687K Buy
10,000
+4,300
+75% +$309K 0.02% 450
2015
Q4
$498K Sell
5,700
-11,000
-66% -$942K 0.01% 655
2015
Q3
$1.35M Sell
16,700
-35,000
-68% -$3.05M 0.04% 415
2015
Q2
$4.6M Buy
51,700
+11,700
+29% +$1.02M 0.13% 140
2015
Q1
$3.47M Buy
+40,000
New +$3.35M 0.07% 163
2014
Q4
Sell
-30,000
Closed -$2.12M 1621
2014
Q3
$2.12M Buy
+30,000
New +$2.14M 0.04% 441
2014
Q2
Sell
-49,200
Closed -$3.69M 1589
2014
Q1
$3.69M Sell
49,200
-10,400
-17% -$779K 0.07% 249
2013
Q4
$4.19M Buy
+59,600
New +$3.89M 0.06% 273

Other funds holding ESRX

Integral Derivatives's ESRX Position: Q3 2016 in Review

Integral Derivatives sold out of Express Scripts Holding Company (ESRX) in Q3 2016, closing a stake of 13,101 shares — an estimated $993K sold.

Integral Derivatives first reported a position in ESRX in Q2 2014 and held it in 8 quarters. The position peaked at $1.14M in Q4 2014. 1,150 funds tracked by Wall St. Rank hold ESRX as of Q3 2016.

  • Integral Derivatives reported no remaining Express Scripts Holding Company position as of Q3 2016 after selling out during the quarter.
  • Integral Derivatives sold 13,101 Express Scripts Holding Company shares in Q3 2016, an estimated $993K.
  • Integral Derivatives first reported a position in Express Scripts Holding Company in Q2 2014 and held it in 8 quarters.
  • Integral Derivatives's Express Scripts Holding Company position peaked at $1.14M in Q4 2014.
  • 1,150 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q3 2016.

Based on Integral Derivatives's 13F filing for Q3 2016, filed 14 Nov 2016.